Search - tctmd.com

Displaying 61 - 80 of 516

Sort: Relevancy | Date

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

Presenter: Seong Huan Choi

October 25, 2023

Presentation TCT 2023

TCT 603: Single versus Dual Antiplatelet Therapy for Conservatively Managed Spontaneous Coronary Artery Dissection (SCAD) Patients

Presenter: Sophie Offen

October 25, 2023

Presentation TCT 2023

TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

Presenter: Ji-Yeon Kim

October 25, 2023

Presentation TCT 2023

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

Presenter: Myeong-Ki Hong

October 25, 2023

Presentation TCT 2023

TCT 7: Strategy of Dual Antiplatelet Therapy for Patients With ST elevation myocardial infarction or Non-ST elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis

Presenter: Toshiki Kuno

October 24, 2023

Presentation TCT 2023

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

Presenter: Jacqueline Tamis-Holland

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Yael L. Maxwell

October 09, 2023

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Yael L. Maxwell

September 05, 2023

News Conference News ESC 2023

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

Todd Neale

August 26, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Michael O'Riordan

July 20, 2023

News Daily News

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Todd Neale

June 20, 2023

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

L.A. McKeown

May 30, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

Advertisement

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium

TCT 603: Single versus Dual Antiplatelet Therapy for Conservatively Managed Spontaneous Coronary Artery Dissection (SCAD) Patients

TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

TCT 7: Strategy of Dual Antiplatelet Therapy for Patients With ST elevation myocardial infarction or Non-ST elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis

Dual Antiplatelet Therapy After PCI: Considerations for Duration and Choice Of Drug(s)

What’s Going to Be Hot at TCT 2023

Clopidogrel Bests Aspirin Monotherapy After PCI Across Risk Strata

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

STOPDAPT-3: Don’t Skip Out on Aspirin Immediately After PCI

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

What’s Going to Be Hot at ESC 2023?

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

New Chronic Heart Disease Guidelines Update Roles of GDMT, Imaging, and Revascularization

Modifying Antiplatelet Therapy: ARC Consensus Aims to Standardize Definitions

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content